Wall Street loves Edwards Lifesciences again
October 3, 2014 by Brian Johnson
Platinum Management
Platinum fires back at Echo Therapeutics over ‘rogue’ directors
Echo Therapeutics hits back at Platinum Equity
Proxy war rages on at Echo Therapeutics
Echo Therapeutics‘ (NSDQ:ECTE) suspension of operations hasn’t stopped a pair of recently appointed renegade board members from using their perch to agitate for change.
Johnson & Johnson plans to file for approval 30 “major” products | Medtech Wall Street news for the week of May 26, 2014
Zimmer looks to avoid layoffs in Biomet merger | Medtech personnel moves for the week of May 26, 2014
Echo Therapeutics proxy war gets ugly amid alleged threats
Embattled Echo Therapeutics (NSDQ:ECTE) issued a new volley against its proxy war rival and largest shareholder Platinum Group, accusing the activist investor of conspiring to tank the company’s stock.
Stryker faces class action employment claims | Medtech personnel moves for the week of May 19, 2014
Echo Therapeutics battles ‘dissident’ stockholder and pool-industry board nominee
